We are a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Our lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH), for […]

We intend to focus our search for a target operating in an alternative energy industry, including clean energy and storage, smart grid/efficiency, environmental services and recycling, mobility, water and wastewater management, advanced materials and technology enabled services. (Incorporated in the Cayman Islands)  (Note: Spring Valley Acquisition Corp. II priced its SPAC IPO on Oct. 12, […]

(Note: Virax Biolabs Group Limited priced its IPO on July 20, 2022, in sync with the terms in its prospectus: 1.35 million shares at $5 each to raise $6.75 million.) We are a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations […]

We intend to focus on businesses in clean energy sectors that have their primary operations located in the Asia-Pacific region. We will focus on businesses with enterprise values between $200 million and $800 million. We believe that we will add value to these businesses primarily by providing them with access to the U.S. capital markets. (Incorporated in the British […]

(Note: Sharps Technology, Inc. slightly upsized its IPO – a unit offering – at pricing on April 13, 2022, by increasing the number of units to 3.75 million – up from 2.45 million units – and priced each unit at $4.25 – $1 below the bottom of its $5.25-to-$7.25 range – to raise $15.94 million. […]

(Note: VIKASA SPAC Series I Acquisition Corp. withdrew its SPAC IPO plans in an SEC filing dated Jan. 23, 2023. VIKASA SPAC had filed its S-1 on March 18, 2022; confidential paperwork filed Jan. 18, 2022.) We intend to target opportunities and companies that we believe are market leaders in facilitating the transition of the […]

We intend to focus our search on new emerging technology companies with an acute growth potential in Southeast Asia and Australasia in sectors such as the Web 3.0, blockchain, cryptocurrency, digital ledger, e-gaming and other new financial technology and services sectors. (Incorporated in the Cayman Islands) We intend to identify opportunities globally but will focus on […]

(Note: Venice Brands Acquisition Corp. I withdrew its SPAC IPO prospectus in an SEC filing dated March 18, 2022. This SPAC’s S-1 filing was in March 2021.) We intend to focus our search for an initial business combination on companies operating in the consumer products sectors, including but not limited to food and beverage, health […]

(Note: Hexion Holdings Corp. withdrew its IPO prospectus in an SEC filing dated March 17, 2022. American Securities, a New York-based private equity firm, bought Hexion for $30 per share in cash, in a transaction expected to be completed during the first half of 2022, according to Hexion’s announcement on Dec. 20, 2021. Hexion filed […]

(Note: Shanghai-based Pomelo Acquisition Corp. Ltd. withdrew its SPAC IPO plans in an SEC filing dated March 3, 2023.) Our efforts to identify a target business will likely span many industries and regions around the world, but we intend to focus on our search in especially the Asia-Pacific and North America regions. However, we will not consummate our […]